Peer Review History
| Original SubmissionFebruary 14, 2025 |
|---|
|
Dear Dr. Kim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 29 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Atakan Orscelik Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.] Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 3. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical. 4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: This study investigates the association between the proximal and distal middle cerebral artery (MCA) diameter ratio and different pathomechanisms of lenticulostriate artery (LSA) infarction, specifically lipohyalinotic degeneration (LD) and branch atheromatous disease (BAD). The authors retrospectively analyzed 117 patients with acute LSA infarctions, differentiating LD and BAD based on infarct size and axial slice involvement. The study employed computational fluid dynamics (CFD) analysis to assess hemodynamic parameters and identified a significant correlation between a higher proximal/distal M1 diameter ratio and LD. Here are my comments; 1- The differentiation between LD and BAD relies on infarct size and slice-based criteria, which may not always provide a definitive classification. Since vessel wall imaging or perfusion studies could improve diagnostic precision, it would be helpful for the authors to acknowledge these limitations and discuss the potential for misclassification in their findings. 2-The CFD analysis provides valuable insights, but its assumptions oversimplify real-world hemodynamics. The use of steady-state modeling and rigid arterial walls does not fully capture the dynamic nature of cerebral blood flow. Addressing how these limitations might affect the results and considering alternative modeling approaches would improve the robustness of the conclusions. 3-The single-center study design with a relatively small sample size raises concerns about generalizability. Given the potential variations in cerebrovascular anatomy across populations, a larger multicenter validation would be necessary to confirm the findings. The authors should discuss this limitation and its implications for broader clinical application. The manuscript presents a novel perspective on MCA geometry and LSA infarction but requires significant revision for clarity, methodological rigor, and validation. Reviewer #2: This manuscript presents an original and methodologically sound investigation into the relationship between the proximal-to-distal diameter ratio of the middle cerebral artery (M1 segment) and the underlying mechanism of lenticulostriate artery (LSA) infarction, particularly in distinguishing between lipohyalinotic degeneration (LD) and branch atheromatous disease (BAD). The study brings together vascular geometry, neuroimaging, and computational fluid dynamics (CFD) modeling in a well-integrated, multidisciplinary approach that offers meaningful insights. The manuscript is clearly structured, and the narrative flows well. The data analysis appears appropriate, and the conclusions are thoughtfully derived from the presented results. By exploring anatomical and hemodynamic determinants of stroke subtypes, the study adds a meaningful contribution to the field. To enhance clarity and reproducibility, the following points are offered for consideration: 1. Methodological and Interpretive Considerations - Variability in M1 diameter measurements on MRA may arise due to inter- and intra-observer differences. Including a brief explanation of how measurement reliability was ensured would help strengthen the methodological transparency. - Conventional MRA techniques, such as time-of-flight (TOF) MRA, may have limited sensitivity in detecting plaques that cause only mild luminal narrowing (e.g., <50%). It might be helpful to briefly mention this limitation in the manuscript. If vessel wall imaging was performed in any case, including those findings could add useful context. - Since the CFD simulations were based on idealized rather than patient-specific geometries, a brief discussion regarding anatomical variability and related limitations could provide additional context. - The inclusion of ROC analysis (e.g., AUC, sensitivity, specificity), along with a proposed cut-off value for the M1 diameter ratio, may help improve the clinical relevance of the findings. 2. Figure Presentation - In Figure 1, some label texts seem to lack sufficient contrast with the background, which may reduce readability. Adjusting text color or weight could enhance visual clarity. - Figure 2 appears to have relatively low resolution. A higher-quality version would likely improve overall image presentation. - In Figure 3, several text labels look slightly distorted or unclear. Improving the sharpness and clarity of these labels may enhance the figure's effectiveness. These comments are shared in a collaborative and respectful spirit, with appreciation for the authors’ thoughtful contribution. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Yigit Can Senol Reviewer #2: Yes: Il Kwon ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Proximal and distal middle cerebral artery diameter ratio and lenticulostriate artery infarction PONE-D-25-05856R1 Dear Dr. Kim, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Atakan Orscelik Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: thank you for adressing my comments, i have no further comments and I congratulate authors for their hardwork! Reviewer #2: The revised manuscript exhibits enhanced clarity, methodological rigor, and transparency. Inter‑observer reliability with ICC values is now included; the discussion accurately addresses TOF‑MRA’s limitations and the potential of vessel‑wall imaging; key CFD assumptions are explicitly stated; and ROC analysis with quantitative metrics has been incorporated. The authors have also refined the manuscript’s focus by deferring the MCA tortuosity analysis, which appropriately streamlines this version. These updates meaningfully strengthen the study. The authors’ scholarly diligence and respectful engagement throughout the revision process are commendable. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Il Kwon ********** |
| Formally Accepted |
|
PONE-D-25-05856R1 PLOS ONE Dear Dr. Kim, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Atakan Orscelik Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .